These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5864716)

  • 21. Lipophilicity study of salicylamide.
    Medić-Sarić M; Mornar A; Jasprica I
    Acta Pharm; 2004 Jun; 54(2):91-101. PubMed ID: 15274753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of portacaval shunt on the disposition of drugs with and without first-pass effect.
    Gugler R; Lain P; Azarnoff DL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):416-23. PubMed ID: 1195128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Availability of plasma sulfate for conjugation of salicylamide in dogs.
    Waschek JA; Fielding RM; Tozer TN; Effeney DJ; Pond SM
    Biochem Pharmacol; 1986 Feb; 35(3):544-6. PubMed ID: 3947388
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of sulfate formation in biotransformation of salicylamide in man.
    Levy G; Matsuzawa T
    J Pharm Sci; 1966 Feb; 55(2):222-3. PubMed ID: 5923280
    [No Abstract]   [Full Text] [Related]  

  • 25. THE ABSORPTION OF SALICYLAMIDE IN PERNICIOUS ANEMIA, GASTRIC ACHYLIA AND PEPTIC ULCER.
    HARTIALA K; KASANEN A; RAUSSI M
    Ann Med Exp Biol Fenn; 1963; 41():549-53. PubMed ID: 14078783
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetics of salicylamide elimination in man.
    Levy G; Matsuzawa T
    J Pharmacol Exp Ther; 1967 May; 156(2):285-93. PubMed ID: 6026259
    [No Abstract]   [Full Text] [Related]  

  • 27. Excretion of D-glucaric acid and metabolism of salicylamide in man: the effect of phenobarbital-produced enzymatic induction.
    Drzewiecki J
    Pol J Pharmacol Pharm; 1977; 29(4):359-66. PubMed ID: 905203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations in salicylamide glucuronide formation in normal and in G-6-PD-deficient children.
    Cassimos C; Malaka-Zafiriu K; Tsiures T; Danielides B
    J Pediatr; 1974 Jan; 84(1):110-1. PubMed ID: 12119928
    [No Abstract]   [Full Text] [Related]  

  • 29. High-performance liquid chromatographic method for the quantitation of salicylamide and its metabolites in biological fluids.
    Xu X; Pang KS
    J Chromatogr; 1987 Sep; 420(2):313-27. PubMed ID: 3693503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salicylamide metabolism in acute intermittent porphyria.
    Song CS; Bonkowsky HL; Tschudy DP
    Clin Pharmacol Ther; 1974 Apr; 15(4):431-5. PubMed ID: 4821444
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of route of administration on competitive drug biotransformation interaction: salicylamide-ascorbic acid interaction in rats.
    Houston JB; Levy G
    J Pharmacol Exp Ther; 1976 Aug; 198(2):284-94. PubMed ID: 948026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diminished activity of the hepatic glucuronation of the salicylamide in subjects with erythrocyte deficiency of glucosephosphate dehydrogenase (G-6-PD)].
    Cutillo S
    Pediatria (Napoli); 1975 Sep; 83(3):vi-vii. PubMed ID: 1223739
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic quercetin feeding decreases plasma concentrations of salicylamide phase II metabolites in pigs following oral administration.
    Wein S; Cermak R; Wolffram S; Langguth P
    Xenobiotica; 2012 May; 42(5):477-82. PubMed ID: 22188411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
    Pang KS; Barker F; Schwab AJ; Goresky CA
    J Pharmacol Exp Ther; 1994 Jul; 270(1):285-95. PubMed ID: 8035326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of ethyl 2-carbamoyloxybenzoate (4003/2), a prodrug of salicylic acid, carsalam and salicylamide.
    Kamal A
    Biochem Pharmacol; 1990 Oct; 40(7):1669-71. PubMed ID: 2222521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissolution rates of caffeine and salicylamide from tablets.
    Nerlo H; Czarnecki W; Dul R
    Pol J Pharmacol Pharm; 1974; 26(5):549-53. PubMed ID: 4427817
    [No Abstract]   [Full Text] [Related]  

  • 37. Absorption and distribution of salicylamide.
    SEEBERG VP; HANSEN D; WHITNEY B
    J Pharmacol Exp Ther; 1951 Mar; 101(3):275-82. PubMed ID: 14825083
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanism of intestinal absorption of drugs from oil in water emulsions. II. Absorption from oily solutions.
    Kakemi K; Sezaki H; Muranishi S; Ogata H; Giga K
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):715-20. PubMed ID: 5045613
    [No Abstract]   [Full Text] [Related]  

  • 39. Salicylamide sulfate cell entry in perfused rat liver: a multiple-indicator dilution study.
    Xu X; Schwab AJ; Barker F; Goresky CA; Pang KS
    Hepatology; 1994 Jan; 19(1):229-44. PubMed ID: 8276359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic analysis of pharmacological effects and drug disposition. II. Effects of salicylamide and afebrile rats.
    Kakemi M; Kobayashi T; Mamuro C; Ueda M; Koizumi T
    Chem Pharm Bull (Tokyo); 1976 Sep; 24(9):2254-7. PubMed ID: 991370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.